BIZ NEWS: Are These 2 Beaten-Down Biotech Stocks Worth the Risk? - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Thursday, 16 May 2019

BIZ NEWS: Are These 2 Beaten-Down Biotech Stocks Worth the Risk?


Are These 2 Beaten-Down Biotech Stocks Worth the Risk?



Catalyst Pharmaceuticals and Novavax have had tough go of it in May. Could better days be close at hand?

via FOX BUSINESS NEWS https://fxn.ws/2vYRyHK

No comments:

Post a Comment

Post Top Ad